Royce & Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Sell |
1,276,856
-51,588
| -4% | -$124K | 0.03% | 544 |
|
|
2025
Q1 | $2.94M | Buy |
1,328,444
+369,559
| +39% | +$817K | 0.03% | 529 |
|
|
2024
Q4 | $5.23M | Buy |
958,885
+50,107
| +6% | +$273K | 0.05% | 467 |
|
|
2024
Q3 | $7.55M | Buy |
908,778
+514,332
| +130% | +$4.27M | 0.07% | 388 |
|
|
2024
Q2 | $2.82M | Buy |
394,446
+378,009
| +2,300% | +$2.71M | 0.03% | 579 |
|
|
2024
Q1 | $143K | Buy |
+16,437
| New | +$143K | ﹤0.01% | 844 |
|
|
2023
Q1 | – | Sell |
-54,106
| Closed | -$774K | – | 937 |
|
|
2022
Q4 | $774K | Buy |
+54,106
| New | +$774K | 0.01% | 784 |
|
|
2022
Q3 | – | Sell |
-458,788
| Closed | -$13M | – | 956 |
|
|
2022
Q2 | $13M | Buy |
458,788
+109,303
| +31% | +$3.11M | 0.13% | 224 |
|
|
2022
Q1 | $12.3M | Buy |
+349,485
| New | +$12.3M | 0.1% | 293 |
|